X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15090) 15090
Publication (1378) 1378
Book Review (331) 331
Book Chapter (19) 19
Conference Proceeding (11) 11
Dissertation (4) 4
Magazine Article (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12151) 12151
oncology (9395) 9395
index medicus (9010) 9010
female (6262) 6262
phase-ii (5832) 5832
chemotherapy (5358) 5358
male (5093) 5093
middle aged (4988) 4988
aged (4707) 4707
cancer (4639) 4639
phase-ii trial (4522) 4522
adult (4084) 4084
treatment outcome (3756) 3756
antineoplastic combined chemotherapy protocols - therapeutic use (3339) 3339
care and treatment (2844) 2844
antineoplastic agents - therapeutic use (2711) 2711
medicine & public health (2207) 2207
pharmacology & pharmacy (1947) 1947
therapy (1876) 1876
research (1835) 1835
hematology (1810) 1810
aged, 80 and over (1805) 1805
prognosis (1702) 1702
metastasis (1596) 1596
disease-free survival (1587) 1587
trial (1560) 1560
clinical trials (1552) 1552
survival (1545) 1545
drug therapy (1541) 1541
cisplatin (1476) 1476
multicenter (1423) 1423
health aspects (1416) 1416
clinical trials, phase ii as topic (1402) 1402
antineoplastic combined chemotherapy protocols - adverse effects (1386) 1386
neoplasm staging (1381) 1381
animals (1325) 1325
retrospective studies (1313) 1313
surgery (1294) 1294
tumors (1272) 1272
survival rate (1256) 1256
survival analysis (1254) 1254
analysis (1247) 1247
radiotherapy (1223) 1223
clinical trials as topic (1142) 1142
carcinoma (1126) 1126
breast cancer (1120) 1120
combined modality therapy (1106) 1106
breast neoplasms - drug therapy (1094) 1094
combination (1056) 1056
hematology, oncology and palliative medicine (1044) 1044
gemcitabine (1040) 1040
open-label (1036) 1036
lung neoplasms - drug therapy (1031) 1031
multicenter phase-ii (1029) 1029
deoxycytidine - analogs & derivatives (1005) 1005
drug administration schedule (1003) 1003
antineoplastic agents - adverse effects (955) 955
antineoplastic agents (947) 947
neoplasm metastasis (923) 923
cancer therapies (920) 920
paclitaxel (917) 917
randomized controlled trials as topic (900) 900
double-blind (895) 895
patients (891) 891
1st-line treatment (880) 880
docetaxel (879) 879
antimitotic agents (877) 877
immunotherapy (869) 869
antineoplastic agents - administration & dosage (866) 866
antibodies, monoclonal - therapeutic use (853) 853
antineoplastic combined chemotherapy protocols - administration & dosage (853) 853
randomized-trial (838) 838
review (810) 810
bevacizumab (808) 808
follow-up studies (799) 799
disease progression (792) 792
efficacy (789) 789
cancer research (783) 783
carcinoma, non-small-cell lung - drug therapy (778) 778
development and progression (745) 745
risk factors (739) 739
deoxycytidine - administration & dosage (736) 736
toxicity (720) 720
antineoplastic agents - pharmacology (716) 716
cell lung-cancer (703) 703
patient outcomes (692) 692
prospective studies (686) 686
growth-factor receptor (684) 684
radiation-therapy (681) 681
fluorouracil (676) 676
dose-response relationship, drug (671) 671
adolescent (668) 668
article (667) 667
fluorouracil - administration & dosage (665) 665
cisplatin - administration & dosage (659) 659
clinical trials, phase iii as topic (659) 659
capecitabine (655) 655
breast neoplasms - pathology (653) 653
rituximab (652) 652
young adult (649) 649
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14898) 14898
French (87) 87
German (68) 68
Spanish (19) 19
Italian (7) 7
Japanese (7) 7
Polish (7) 7
Korean (5) 5
Russian (3) 3
Chinese (2) 2
Hungarian (2) 2
Esperanto (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 01/2015, Volume 121, Issue 2, pp. 234 - 242
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 67, Issue 2, pp. 241 - 249
Journal Article
Cancer, ISSN 0008-543X, 09/2015, Volume 121, Issue 18, pp. 3290 - 3297
Journal Article
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2003, Volume 14, Issue 8, pp. 1227 - 1233
Journal Article
Journal of Neurology, ISSN 0340-5354, 7/2002, Volume 249, Issue 8, pp. 1088 - 1097
Journal Article
Journal Article
Blood, ISSN 0006-4971, 10/2014, Volume 124, Issue 15, pp. 2354 - 2361
Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a... 
REARRANGEMENT | SURVIVAL | TRANSLOCATION | POOR-PROGNOSIS | RITUXIMAB | MYC | PHASE-II | GERMINAL CENTER | INDEX | HEMATOLOGY | EXPRESSION | Multivariate Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Remission Induction | Stem Cell Transplantation | Young Adult | Disease-Free Survival | Lymphoma - therapy | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies
Journal Article
Journal Article